|
Name |
Benzeneethanol, 4-(acetyloxy)-
|
Molecular Formula | C10H12O3 | |
IUPAC Name* |
[4-(2-hydroxyethyl)phenyl] acetate
|
|
SMILES |
CC(=O)OC1=CC=C(C=C1)CCO
|
|
InChI |
InChI=1S/C10H12O3/c1-8(12)13-10-4-2-9(3-5-10)6-7-11/h2-5,11H,6-7H2,1H3
|
|
InChIKey |
ZTXTZJHRRIQLRH-UHFFFAOYSA-N
|
|
Synonyms |
Benzeneethanol, 4-(acetyloxy)-; 60037-43-6; [4-(2-hydroxyethyl)phenyl] acetate; 4-(2-Hydroxyethyl)phenyl acetate; 4-Acetoxybenzeneethanol; 2-(4-methylcarbonyloxyphenyl)-1-ethanol; 2-p-acetoxyphenylethanol; 4-Acetoxyphenethyl alcohol; SCHEMBL6662199; 4-(2-Hydroxyethyl)phenylacetate; DTXSID70343012; 4-(2-Hydroxyethyl)phenyl acetate #
|
|
CAS | 60037-43-6 | |
PubChem CID | 586676 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 180.2 | ALogp: | 1.3 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 46.5 | Aromatic Rings: | 1 |
Heavy Atoms: | 13 | QED Weighted: | 0.567 |
Caco-2 Permeability: | -4.268 | MDCK Permeability: | 0.00003200 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.046 |
30% Bioavailability (F30%): | 0.954 |
Blood-Brain-Barrier Penetration (BBB): | 0.982 | Plasma Protein Binding (PPB): | 47.54% |
Volume Distribution (VD): | 0.619 | Fu: | 62.56% |
CYP1A2-inhibitor: | 0.549 | CYP1A2-substrate: | 0.112 |
CYP2C19-inhibitor: | 0.317 | CYP2C19-substrate: | 0.23 |
CYP2C9-inhibitor: | 0.091 | CYP2C9-substrate: | 0.729 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.444 |
CYP3A4-inhibitor: | 0.022 | CYP3A4-substrate: | 0.314 |
Clearance (CL): | 6.226 | Half-life (T1/2): | 0.836 |
hERG Blockers: | 0.02 | Human Hepatotoxicity (H-HT): | 0.033 |
Drug-inuced Liver Injury (DILI): | 0.147 | AMES Toxicity: | 0.047 |
Rat Oral Acute Toxicity: | 0.025 | Maximum Recommended Daily Dose: | 0.254 |
Skin Sensitization: | 0.9 | Carcinogencity: | 0.874 |
Eye Corrosion: | 0.203 | Eye Irritation: | 0.984 |
Respiratory Toxicity: | 0.035 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001422 | 0.532 | D02HXS | 0.421 | ||||
ENC005495 | 0.531 | D03XTC | 0.382 | ||||
ENC000350 | 0.524 | D05CKR | 0.377 | ||||
ENC000223 | 0.488 | D01UXC | 0.375 | ||||
ENC000870 | 0.469 | D02AQY | 0.370 | ||||
ENC005828 | 0.456 | D0B3QM | 0.352 | ||||
ENC005827 | 0.456 | D0I2MK | 0.348 | ||||
ENC002242 | 0.440 | D0GY5Z | 0.340 | ||||
ENC005811 | 0.426 | D01CRB | 0.340 | ||||
ENC005812 | 0.426 | D0VB0U | 0.333 |